Infliximab Limits Injury in Myocardial Infarction

Background The purpose of this study was to investigate a therapeutic approach targeting the inflammatory response and consequent remodeling from ischemic myocardial injury. Methods and Results Coronary thrombus aspirates were collected from patients at the time of ST‐segment–elevation myocardial in...

Full description

Bibliographic Details
Published in:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Main Authors: Christopher Livia, Sara Inglis, Ruben Crespo‐Diaz, Skylar Rizzo, Ryan Mahlberg, Monique Bagwell, Matthew Hillestad, Satsuki Yamada, Dhivya Vadhana Meenakshi Siddharthan, Raman Deep Singh, Xing Li, D. Kent Arrell, Paul Stalboerger, Tyra Witt, Abdallah El Sabbagh, Munveer Rihal, Charanjit Rihal, Andre Terzic, Jozef Bartunek, Atta Behfar
Format: Article
Language:English
Published: Wiley 2024-05-01
Subjects:
immune modulation
infliximab
myocardial infarction
porcine model
TNFα inhibition
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.032172

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.123.032172

Similar Items